You just read:

U.S. and China Asthma and COPD Drugs Market to be Worth US$18.7 Bn by 2024: Development of New Biologics to Combat Respiratory Diseases to Provide Strong Impetus, Predicts TMR

News provided by

Transparency Market Research

Oct 18, 2016, 10:30 ET